Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ANIK similar filings
- 7 May 20 Anika Reports First Quarter 2020 Financial Results
- 29 Apr 20 Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer
- 8 Apr 20 Anika Takes Actions to Strengthen Liquidity in Light of COVID-19
- 13 Mar 20 Financial Statements and Exhibits
- 2 Mar 20 Departure of Directors or Certain Officers
- 20 Feb 20 Anika Reports Fourth Quarter and Full Year 2019 Financial Results
- 14 Feb 20 Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference on Form 8-K (No. 001-14027/20545479) of Anika Therapeutics Inc. of our audit report dated December 11, 2019 (reissued on December 18, 2019), with respect to the financial statements of Parcus Medical, LLC, appearing in this Form 8-K/A.
Warren Averett
March 12, 2020